Sofinnova Investments, Inc. Bluebird Bio, Inc. Transaction History

Sofinnova Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$3.14 - $8.22 $2.11 Million - $5.53 Million	672,815 New	672,815 $2.14 Million
Q3 2018 Nov 15, 2018	SELL	$88.86 - $117.49 $4.92 Million - $6.51 Million	-55,371 Closed	0 $0
Q2 2018 Nov 15, 2018	BUY	$99.64 - $127.59 $4.95 Million - $6.34 Million	49,664 Added 870.23%	55,371 $8.69 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $568,645 - $728,156	5,707 New	5,707 $896,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.